Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 24:386:e078918.
doi: 10.1136/bmj-2023-078918.

Personal protective effect of wearing surgical face masks in public spaces on self-reported respiratory symptoms in adults: pragmatic randomised superiority trial

Affiliations

Personal protective effect of wearing surgical face masks in public spaces on self-reported respiratory symptoms in adults: pragmatic randomised superiority trial

Runar Barstad Solberg et al. BMJ. .

Erratum in

Abstract

Objective: To evaluate the personal protective effects of wearing versus not wearing surgical face masks in public spaces on self-reported respiratory symptoms over a 14 day period.

Design: Pragmatic randomised superiority trial.

Setting: Norway.

Participants: 4647 adults aged ≥18 years: 2371 were assigned to the intervention arm and 2276 to the control arm.

Interventions: Participants in the intervention arm were assigned to wear a surgical face mask in public spaces (eg, shopping centres, streets, public transport) over a 14 day period (mask wearing at home or work was not mentioned). Participants in the control arm were assigned to not wear a surgical face mask in public places.

Main outcome measures: The primary outcome was self-reported respiratory symptoms consistent with a respiratory infection. Secondary outcomes included self-reported and registered covid-19 infection.

Results: Between 10 February 2023 and 27 April 2023, 4647 participants were randomised of whom 4575 (2788 women (60.9%); mean age 51.0 (standard deviation 15.0) years) were included in the intention-to-treat analysis: 2313 (50.6%) in the intervention arm and 2262 (49.4%) in the control arm. 163 events (8.9%) of self-reported symptoms consistent with respiratory infection were reported in the intervention arm and 239 (12.2%) in the control arm. The marginal odds ratio was 0.71 (95% confidence interval (CI) 0.58 to 0.87; P=0.001) favouring the face mask intervention. The absolute risk difference was -3.2% (95% CI -5.2% to -1.3%; P<0.001). No statistically significant effect was found on self- reported (marginal odds ratio 1.07, 95% CI 0.58 to 1.98; P=0.82) or registered covid-19 infection (effect estimate and 95% CI not estimable owing to lack of events in the intervention arm).

Conclusion: Wearing a surgical face mask in public spaces over 14 days reduces the risk of self-reported symptoms consistent with a respiratory infection, compared with not wearing a surgical face mask.

Trial registration: ClinicalTrials.gov NCT05690516.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure at www.icmj.org/disclosure-of-interest/ and declare: support from the Centre for Epidemic Interventions Research, Norwegian Institute of Public Health; no financial relationship with any organisation that might have an interest in the submitted work in previous three years; AF has received financial support from the World Health Organization (WHO) to attend meetings it has hosted; CR is named inventor on a patent application related to vaccine development. LGH’s institution (RC2NB) was contracted by WHO for the development of study protocol templates to evaluate public health and social measures; LGH received travel support from WHO; no other relationships or activities that could appear to have influenced the submitted work.

Figures

Fig 1
Fig 1
Flow of participants through trial
Fig 2
Fig 2
Prespecified subgroup analysis on the intervention effect of wearing surgical face masks
None

Comment in

References

    1. WHO. COVID-19 DASHBOARD 2023. https://covid19.who.int/.
    1. Rowe BR, Canosa A, Meslem A, Rowe F. Increased airborne transmission of COVID-19 with new variants, implications for health policies. Build Environ 2022;219:109132. 10.1016/j.buildenv.2022.109132. - DOI - PMC - PubMed
    1. Talic S, Shah S, Wild H, et al. Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis. BMJ 2021;375:e068302. 10.1136/bmj-2021-068302. - DOI - PMC - PubMed
    1. Hirt J, Janiaud P, Hemkens LG. Randomized trials on non-pharmaceutical interventions for COVID-19: a scoping review. BMJ Evid Based Med 2022;27:334-44. 10.1136/bmjebm-2021-111825. - DOI - PMC - PubMed
    1. Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schünemann HJ, COVID-19 Systematic Urgent Review Group Effort (SURGE) study authors . Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet 2020;395:1973-87. 10.1016/S0140-6736(20)31142-9. - DOI - PMC - PubMed

Publication types

MeSH terms

Associated data